Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces today that the positive results of a...
Source: prnewswire.com